Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | CASP6 | P55212 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | NSD2 | O96028 | 3/20 | 0.46 |
| ▸ | SNCA | P37840 | 2/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27722383 | 1.00 | NT5E (0.50) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL1432844 | 1.00 | NT5E (0.50) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL27701841 | 1.00 | NT5E (0.50) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL29364767 | 0.98 | NT5E (0.51) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL2926553 | 0.98 | NT5E (0.51) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL589951 | 0.98 | NT5E (0.51) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL31615002 | 0.98 | NT5E (0.51) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL30607134 | 0.98 | NT5E (0.51) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| Potassium SCHEMBL18274866 | 0.96 | NT5E (0.50) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 | |
| SCHEMBL18274864 | 0.96 | NT5E (0.50) | NT5EHSD17B10ALDH1A1CASP6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11752086-B2 | Topical formulations and methods | MYOCEPT INC. (US) | 2023-09-12 | — | — | US | disclosed |
| CN-111182884-B | Inorganic sunscreen coated with adducts of hydroxycinnamic esters and silanols | 维佐尔有限责任公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-113698792-B | Preparation method of azo lake organic pigment capable of reducing aromatic amine residues | 百合花集团股份有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-110462108-B | Electroplating solution | 三菱综合材料株式会社 | 2022-02-01 | — | — | CN | disclosed |
| CN-113698792-A | Preparation method of azo lake organic pigment capable of reducing aromatic amine residues | 百合花集团股份有限公司 | 2021-11-26 | — | — | CN | disclosed |
| US-20210179975-A1 | COMPOSITION CONTAINING LANTHANIDE METAL COMPLEX | SPECIALTY OPERATIONS FRANCE (FR) | 2021-06-17 | — | — | US | disclosed |
| CN-108409542-B | Method for synthesizing 2, 3-dihydroxynaphthalene | 南通柏盛化工有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-108530465-B | Visible light sensitive information recording material and preparation method thereof | 北京化工大学 | 2020-06-05 | — | — | CN | disclosed |
| CN-110612093-A | Topical formulations and methods | 麦欧赛普特股份有限公司 | 2019-12-24 | — | — | CN | disclosed |
| US-20170105968-A1 | Compositions and Methods for Treatment of Inflammatory Skin Conditions Using Allantoin | SCIODERM, INC. (US) | 2017-04-20 | — | — | US | disclosed |
| US-20020054895-A1 | And at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectants | ALWYN COMPANY, INC. | 2002-05-09 | — | — | US | disclosed |
| US-20020055531-A1 | Methods for treatment of inflammatory diseases | SWEEN, MAURICE ALWYN | 2002-05-09 | — | — | US | disclosed |
| US-6376557-B1 | TRANSDERMAL SUPPLYING | ZAVERI CHANDA BHUWALKA (US) | 2002-04-23 | — | — | US | disclosed |
| WO-2001068107-A1 | HAIR RESTORATION FORMULATION | ZAVERI CHANDA BHUWALKA (US) | 2001-09-20 | — | — | WO | disclosed |
| US-5642209-A | FOR EXPOSING A PHOTOSENSITIVE SUBSTRATE | BAKER KENNETH M (US) | 1997-06-24 | — | — | US | disclosed |
| US-5427677-A | Using a naphthalenesulfonic acid | LEARONAL, INC. (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0613028-A2 | Directional light filter and holographic projector system for its production | Baker, Kenneth M. (US) | 1994-08-31 | — | — | EP | disclosed |
| US-5286704-A | Heat-sensitive recording medium | HONSHU PAPER CO., LTD. (JP) | 1994-02-15 | — | — | US | disclosed |
| EP-0496017-A1 | Heat-sensitive recording medium | HONSHU PAPER CO., LTD. (JP) | 1992-07-29 | — | — | EP | disclosed |
| US-4659643-A | A PHENOXY COMPOUND | KANZAKI PAPER MANUFACTURING CO. LTD. (JP) | 1987-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170105968-A1 | Compositions and Methods for Treatment of Inflammatory Skin Conditions Using Allantoin | CUTA, ITCH, ARG1 | NT5E 4831/4885HSD17B10 3316/4885ALDH1A1 2205/4885 |
| US-11752086-B2 | Topical formulations and methods | KRT18, ANXA3, VIP | NT5E 2813/4885HSD17B10 2793/4885ALDH1A1 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.